Eprex and Thalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eprex (epoetin alfa) and Thalidomide (thalidomide). Common drug interactions include pneumonia among females and varicella among males.

The phase IV clinical study analyzes what interactions people have when they take Eprex and Thalidomide. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Eprex?

Eprex has active ingredients of epoetin alfa. eHealthMe is studying from 5,554 Eprex users. Check the latest studies of Eprex.

What is Thalidomide?

Thalidomide has active ingredients of thalidomide. eHealthMe is studying from 16,473 Thalidomide users. Check the latest studies of Thalidomide.



On Aug, 05, 2026

49 people who take Eprex and Thalidomide together, and have interactions are studied.

Eprex and Thalidomide drug interactions.

What are the common drug interactions of Eprex and Thalidomide, by gender? *:

female:

  1. Pneumonia
  2. Abdominal wall abscess (abdominal wall infection)
  3. Asthenia (weakness)
  4. Back pain
  5. Enterocutaneous fistula
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. General physical health deterioration (weak health status)
  8. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  9. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  10. Refractory anaemia with ringed sideroblasts (this type involves a low number of red blood cells. the existing red blood cells contain excess amounts of iron)

male:

  1. Varicella
  2. Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
  3. Infarction (obstruction of the blood supply to an organ or region of tissue)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Urinary retention (the inability to completely or partially empty the bladder)
  8. Cough
  9. Drug hypersensitivity
  10. Herpes zoster

What are the common drug interactions of Eprex and Thalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Purpura (purplish discoloration of the skin)
  2. Thrombocytopenia (decrease of platelets in blood)

60+:

  1. Varicella
  2. Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Tachypnoea (a condition of rapid breathing over 20 per minute)
  5. General physical health deterioration (weak health status)
  6. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  7. Confusional state
  8. Disease progression
  9. Eosinophil count increased
  10. Generalised erythema (redness of the skin all over the body)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 48 people, 97.96%
  2. Enlarged Prostate: 19 people, 38.78%
  3. High Blood Pressure: 14 people, 28.57%
  4. Urinary Tract Infection: 10 people, 20.41%
  5. Constipation: 10 people, 20.41%
  6. Anaemia (lack of blood): 7 people, 14.29%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 12.24%
  8. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 12.24%
  9. Pyelonephritis Acute (sudden inflammation of kidney caused by bacteria): 5 people, 10.20%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 10.20%

* Approximation only. Some reports may have incomplete information.

Do you take Eprex and Thalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Eprex and Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Eprex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eprex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on epoetin alfa and thalidomide (the active ingredients of Eprex and Thalidomide, respectively), and Eprex and Thalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: